This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (446)

Published on in Vol 7 , No 1 (2018) :January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/8794, first published .
Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study

Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study

Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study

Authors of this article:

Ruth Ann Marrie 1 Author Orcid Image ;   Lesley Graff 1 Author Orcid Image ;   John R Walker 1 Author Orcid Image ;   John D Fisk 2 Author Orcid Image ;   Scott B Patten 3 Author Orcid Image ;   Carol A Hitchon 1 Author Orcid Image ;   Lisa M Lix 1 Author Orcid Image ;   James Bolton 1 Author Orcid Image ;   Jitender Sareen 1 Author Orcid Image ;   Alan Katz 1 Author Orcid Image ;   Lindsay I Berrigan 4 Author Orcid Image ;   James J Marriott 1 Author Orcid Image ;   Alexander Singer 1 Author Orcid Image ;   Renée El-Gabalawy 1 Author Orcid Image ;   Christine A Peschken 1 Author Orcid Image ;   Ryan Zarychanski 1 Author Orcid Image ;   Charles N Bernstein 1 Author Orcid Image
Article Authors Cited by (24) Tweetations (1) Metrics

Journals

  1. Enns M, Bernstein C, Kroeker K, Graff L, Walker J, Lix L, Hitchon C, El-Gabalawy R, Fisk J, Marrie R, Soundy A. The association of fatigue, pain, depression and anxiety with work and activity impairment in immune mediated inflammatory diseases. PLOS ONE 2018;13(6):e0198975 View
  2. Hitchon C, Zhang L, Peschken C, Lix L, Graff L, Fisk J, Patten S, Bolton J, Sareen J, El‐Gabalawy R, Marriott J, Bernstein C, Marrie R. Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis. Arthritis Care & Research 2020;72(8):1130 View
  3. Lewis K, Marrie R, Bernstein C, Graff L, Patten S, Sareen J, Fisk J, Bolton J, Marrie R, Bolton J, Sareen J, Walker J, Patten S, Singer A, Lix L, Hitchon C, El-Gabalawy R, Katz A, Fisk J, Bernstein C, Graff L, Berrigan L, Zarychanski R, Peschken C, Marriott J. The Prevalence and Risk Factors of Undiagnosed Depression and Anxiety Disorders Among Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019;25(10):1674 View
  4. Whitehouse C, Fisk J, Bernstein C, Berrigan L, Bolton J, Graff L, Hitchon C, Marriott J, Peschken C, Sareen J, Walker J, Stewart S, Marrie R. Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders. Neurology 2019;92(5):e406 View
  5. Reinhorn I, Bernstein C, Graff L, Patten S, Sareen J, Fisk J, Bolton J, Hitchon C, Marrie R. Social phobia in immune-mediated inflammatory diseases. Journal of Psychosomatic Research 2020;128:109890 View
  6. Marrie R, Walker J, Graff L, Patten S, Bolton J, Marriott J, Fisk J, Hitchon C, Peschken C, Bernstein C. Gender differences in information needs and preferences regarding depression among individuals with multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis. Patient Education and Counseling 2019;102(9):1722 View
  7. Carney H, Marrie R, Bolton J, Patten S, Graff L, Bernstein C, Kowalec K. Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2021;27(1):58 View
  8. Orr J, Bernstein C, Graff L, Patten S, Bolton J, Sareen J, Marriott J, Fisk J, Marrie R. Factors associated with perceived need for mental health care in multiple sclerosis. Multiple Sclerosis and Related Disorders 2018;25:179 View
  9. Marrie R, Patel R, Figley C, Kornelsen J, Bolton J, Graff L, Mazerolle E, Marriott J, Bernstein C, Fisk J. Diabetes and anxiety adversely affect cognition in multiple sclerosis. Multiple Sclerosis and Related Disorders 2019;27:164 View
  10. Tennenhouse L, Marrie R, Bernstein C, Lix L. Machine-learning models for depression and anxiety in individuals with immune-mediated inflammatory disease. Journal of Psychosomatic Research 2020;134:110126 View
  11. Marrie R, Patel R, Bernstein C, Bolton J, Graff L, Marriott J, Hitchon C, Figley C, Kornelsen J, Fisk J. Anxiety and depression affect performance on the symbol digit modalities test over time in MS and other immune disorders. Multiple Sclerosis Journal 2021;27(8):1284 View
  12. Marrie R, Whitehouse C, Patel R, Figley C, Kornelsen J, Bolton J, Graff L, Mazerolle E, Marriott J, Bernstein C, Fisk J. Performance of Regression-Based Norms for Cognitive Functioning of Persons With Multiple Sclerosis in an Independent Sample. Frontiers in Neurology 2021;11 View
  13. Marrie R, Graff L, Fisk J, Patten S, Bernstein C. The Relationship Between Symptoms of Depression and Anxiety and Disease Activity in IBD Over Time. Inflammatory Bowel Diseases 2021;27(8):1285 View
  14. Marrie R, Patel R, Figley C, Kornelsen J, Bolton J, Graff L, Mazerolle E, Helmick C, O'Grady C, Uddin M, Marriott J, Bernstein C, Fisk J. Higher Framingham Risk Scores are associated with greater loss of brain volume over time in multiple sclerosis. Multiple Sclerosis and Related Disorders 2021;54:103088 View
  15. Su S, Marrie R, Bernstein C. Factors Associated With Social Participation in Persons Living With Inflammatory Bowel Disease. Journal of the Canadian Association of Gastroenterology 2022;5(2):59 View
  16. Leekoff M, Culpepper W, Jin S, Lee-Wilk T, Wallin M. Impact of comorbid post traumatic stress disorder on multiple sclerosis in military veterans: A population-based cohort study. Multiple Sclerosis Journal 2022;28(8):1257 View
  17. Vasileiou E, Hu C, Bernstein C, Lublin F, Wolinsky J, Cutter G, Sotirchos E, Kowalec K, Salter A, Saidha S, Mowry E, Calabresi P, Marrie R, Fitzgerald K. Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis. Neurology - Neuroimmunology Neuroinflammation 2023;10(1):e200062 View
  18. Uddin M, Figley T, Kornelsen J, Mazerolle E, Helmick C, O'Grady C, Pirzada S, Patel R, Carter S, Wong K, Essig M, Graff L, Bolton J, Marriott J, Bernstein C, Fisk J, Marrie R, Figley C. The comorbidity and cognition in multiple sclerosis (CCOMS) neuroimaging protocol: Study rationale, MRI acquisition, and minimal image processing pipelines. Frontiers in Neuroimaging 2022;1 View
  19. Marrie R, Patel R, Figley C, Kornelsen J, Bolton J, Graff L, Mazerolle E, Helmick C, Uddin M, Figley T, Marriott J, Bernstein C, Fisk J. Effects of Vascular Comorbidity on Cognition in Multiple Sclerosis Are Partially Mediated by Changes in Brain Structure. Frontiers in Neurology 2022;13 View
  20. Kowalec K, Carney H, Patel M, Hitchon C, Bolton J, Patten S, Graff L, Bernstein C, Peschken C, Marrie R, Marrie R, Bolton J, Sareen J, Patten S, Singer A, Lix L, Hitchon C, El‐Gabalawy R, Katz A, Fisk J, Bernstein C, Graff L, Berrigan L, Peschken C, Marriott J. Prevalence and Risk Factors of Substance Use Disorder in Rheumatoid Arthritis. ACR Open Rheumatology 2021;3(12):889 View
  21. Wan A, Bernstein C, Graff L, Patten S, Sareen J, Fisk J, Bolton J, Hitchon C, Marriott J, Marrie R. Childhood Maltreatment and Psychiatric Comorbidity in Immune-Mediated Inflammatory Disorders. Psychosomatic Medicine 2022;84(1):10 View
  22. Patel R, Marrie R, Bernstein C, Bolton J, Graff L, Marriott J, Figley C, Kornelsen J, Mazerolle E, Uddin M, Fisk J, Bolton J, Graff L, Kornelsen J, Mazerolle E, Patel R, Figley T, Helmick C. Vascular comorbidity is associated with decreased cognitive functioning in inflammatory bowel disease. Scientific Reports 2023;13(1) View

Books/Policy Documents

  1. Kapfhammer H. Depression, Angst, traumatischer Stress und internistische Erkrankungen. View